Eledon Pharmaceuticals, Inc. ELDN
2.64 USD -0.14 -4.87%
As of Nov 2, 3:58 PM ET
- YTD
- +74.50%
- 1 year
- -39.00%
- Open
- 2.84
- Prev close
- 2.77
- Mkt cap
- 214.12M
- Vol
- 616.30K
- Avg vol
- 935.31K
- EPS
- -0.90
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.55
- High
- 2.86
- Forward P/E
- -3.49
- Beta
- 0.00
- Short ratio
- 0.75
- Inst. own
- 42.88%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.12
- 200-d avg
- 2.88
- 1y target
- 12.50
MAX chart
Chart tools
Chart is warming up
The all-time price history for ELDN has not been loaded yet. Try again in a moment.
Altman Z-Score
-4.09 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
P/E -2.7×
P/S 0.0×
P/B 1.5×
P/FCF -2.0×
EV/EBITDA -2.2×
EV/Sales 0.0×
FCF Yield -50.4%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -56.3%
ROIC -55.1%
ROA -27.0%
Revenue 0.0%
Operating Income -18.0%
EPS (diluted) 25.3%
Free Cash Flow -31.9%
Current Ratio 7.4×
Quick Ratio 7.4×
Debt / Equity 0.0×
Net Debt / EBITDA 0.5×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31